Journal of Medicinal Chemistry (25) Cavalli, A.; Lizzi, F.; Bongarzone, S.; Brun, R.; Krauth-Siegel, R. L.; Bolognesi, M. L. Privileged structure-guided synthesis of quinazo- line derivatives as inhibitors of trypanothione reductase. Bioorg. Med. Chem. Lett. 2009, 19, 3031–3035. (26) Saravanamuthu, A.; Vickers, T. J.; Bond, C. S.; Peterson, M. R.; Hunter, W. N.; Fairlamb, A. H. Two interacting binding sites for quinacrine derivatives in the active site of trypanothione reductase—a template for drug design. J. Biol. Chem. 2004, 279, 29493–29500. (27) Yamamoto, M.; Yamamoto, H. Synthetic studies on quinazo- line derivatives. 2. The reactions of 2-trichloroacetamidobenzophenones and 2-triﬂuoroacetamidobenzophenones with primary amines. Chem. Pharm. Bull. (Tokyo) 1981, 29, 2135–2156. (28) Das, B.; Venkateswarlu, K.; Krishnaiah, M.; Holla, H. An eﬃcient, rapid and regioselective nuclear bromination of aromatics and heteroaromatics with NBS using sulfonic-acid-functionalized silica as a heterogeneous recyclable catalyst. Tetrahedron Lett. 2006, 47, 8693–8697. (29) Miyaura, N.; Suzuki, A. Palladium-catalyzed cross-coupling reactions of organoboron compounds. Chem. Rev. 1995, 95, 2457–2483. (30) Jiang, J. B.; Hesson, D. P.; Dusak, B. A.; Dexter, D. L.; Kang, G. J.; Hamel, E. Synthesis and biological evaluation of 2-styrylquinazo- lin-4(3H)-ones, A new class of antimitotic anticancer agents which inhibit tubulin polymerization. J. Med. Chem. 1990, 33, 1721–1728. (31) Okabe, M.; Sun, R. C. Improved synthesis of 2-amino-5- chlorophenyl-20-pyrrylketone, a key intermediate in the synthesis of HIV Tat-antagonists. Tetrahedron 1995, 51, 1861–1866. (32) Fryer, R. I.; Zhang, P. W.; Rios, R. The synthesis of substituted 2-aminophenyl heterocyclic ketones. Synth. Commun. 1993, 23, 985– 992. (33) Kostakis, I. K.; Elomri, A.; Seguin, E.; Iannelli, M.; Besson, T. Rapid synthesis of 2,3-disubstituted-quinazolin-4-ones enhanced by microwave-assisted decomposition of formamide. Tetrahedron Lett. 2007, 48, 6609–6613. (34) Zimaity, T.; Anwar, M.; Abdelhay, F. I.; Abdelmegeed, M. F. Study of reaction of Grignard reagents with 4-(3H)-quinazolinones and 4H-3,1-benzoxazin-4-ones. Acta Chim. Acad. Sci. Hung. 1975, 87, 251–255. (35) Jones, D. C.; Ariza, A.; Chow, W. H.; Oza, S. L.; Fairlamb, A. H. Comparative structural, kinetic and inhibitor studies of Trypanosoma brucei trypanothione reductase with T. cruzi. Mol. Biochem. Parasitol. 2010, 169, 12–19. (36) Hamilton, C. J.; Saravanamuthu, A.; Eggleston, I. M.; Fairlamb, A. H. Ellman’s-reagent-mediated regeneration of trypanothione in situ: substrate-economical microplate and time-dependent inhibition assays for trypanothione reductase. Biochem. J. 2003, 369, 529–537. (37) Jones, D. C.; Hallyburton, I.; Stojanovski, L.; Read, K. D.; Frearson, J. A.; Fairlamb, A. H. Identiﬁcation of a kappa-opioid agonist as a potent and selective lead for drug development against human African trypanosomiasis. Biochem. Pharmacol. 2010, 80, 1478–1486. (38) Raz, B.; Iten, M.; Grether-Buhler, Y.; Kaminsky, R.; Brun, R. The Alamar Blue assay to determine drug sensitivity of African trypano- somes (Tb. rhodesiense and Tb. gambiense) in vitro. Acta Trop. 1997, 68, 139–147. (39) Hopkins, A. L.; Groom, C. R.; Alex, A. Ligand eﬃciency: a useful metric for lead selection. Drug Discovery Today 2004, 9, 430–431. (40) Bailey, S.; Fairlamb, A. H.; Hunter, W. N. Structure of trypanothione reductase from Crithidia fasciculata at 2.6 Å resolution— enzyme NADP interactions at 2.8 Å resolution. Acta Crystallogr., Sect. D: Biol. Crystallogr. 1994, 50, 139–154. (41) Waters, M. L. Aromatic interactions in model systems. Curr. Opin. Chem. Biol. 2002, 6, 736–741. (42) Chan, C.; Yin, H.; Garforth, J.; McKie, J. H.; Jaouhari, R.; Speers, P.; Douglas, K. T.; Rock, P. J.; Yardley, V.; Croft, S. L.; Fairlamb, A. H. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs. J. Med. Chem. 1998, 41, 148–156. (43) Garforth, J.; Yin, H.; McKie, J. H.; Douglas, K. T.; Fairlamb, A. H. Rational design of selective ligands for trypanothione reductase ARTICLE from Trypanosoma cruzi. Structural eﬀects on the inhibition by dibenza- zepines based on imipramine. J. Enzyme Inhib. 1997, 12, 161–173. (44) Horvath, D. A virtual screening approach applied to the search for trypanothione reductase inhibitors. J. Med. Chem. 1997, 40, 2412– 2423. (45) Iribarne, F.; Paulino, M.; Aguilera, S.; Murphy, M.; Tapia, O. Docking and molecular dynamics studies at trypanothione reductase and glutathione reductase active sites. J. Mol. Model. 2002, 8, 173–183. (46) Lee, M. G. S.; E, Y.; Axelrod, N. Construction of trypanosome artiﬁcial mini-chromosomes. Nucleic Acids Res. 1995, 23, 4893–4899. (47) Martinez-Merino, V.; Cerecetto, H. CoMFA-SIMCA model for antichagasic nitrofurazone derivatives. Bioorg. Med. Chem. 2001, 9, 1025– 1030. (48) Jacoby, E. M.; Schlichting, I.; Lantwin, C. B.; Kabsch, W.; Krauth-Siegel, R. L. Crystal structure of the Trypanosoma cruzi trypa- nothione reductase mepacrine complex. Proteins 1996, 24, 73–80. (49) Meiering, S.; Inhoﬀ, O.; Mies, J.; Vincek, A.; Garcia, G.; Kramer, B.; Dormeyer, M.; Krauth-Siegel, R. L. Inhibitors of Trypanosoma cruzi trypanothione reductase revealed by virtual screening and parallel synthesis. J. Med. Chem. 2005, 48, 4793–4802. (50) Paulino, M.; Iribarne, F.; Hansz, M.; Vega, M.; Seoane, G.; Cerecetto, H.; Di Maio, R.; Caracelli, I.; Zukerman-Schpector, J.; Olea, C.; Stoppani, A. O. M.; Berriman, M.; Fairlamb, A. H.; Tapia, O. Computer assisted design of potentially active anti-trypanosomal com- pounds. J. Mol. Struct. (THEOCHEM) 2002, 584, 95–105. (51) Prieto, J. J.; Talevi, A.; Bruno-Blanch, L. E. Application of linear discriminant analysis in the virtual screening of antichagasic drugs through trypanothione reductase inhibition. Mol. Diversity 2006, 10, 361–375. (52) Salmon-Chemin, L.; Buisine, E.; Yardley, V.; Kohler, S.; Debreu, M. A.; Landry, V.; Sergheraert, C.; Croft, S. L.; Krauth-Siegel, R. L.; Davioud-Charvet, E. 2-and 3-Substituted 1,4-naphthoquinone deriva- tives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicity. J. Med. Chem. 2001, 44, 548–565. (53) Kabsch, W. Evaluation of single-crystal X-ray-diﬀraction data from a position-sensitive detector. J. Appl. Crystallogr. 1988, 21, 916– 924. (54) Kabsch, W. XDS. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2010, 66, 125–132. (55) Emsley, P.; Cowtan, K. Coot: model-building tools for molec- ular graphics. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2004, 60, 2126– 2132. (56) Schuttelkopf, A. W.; van Aalten, D. M. PRODRG: a tool for high-throughput crystallography of protein ligand complexes. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2004, 60, 1355–1363. (57) van Aalten, D. M.; Bywater, R.; Findlay, J. B.; Hendlich, M.; Hooft, R. W.; Vriend, G. PRODRG, a program for generating molecular topologies and unique molecular descriptors from coordinates of small molecules. J. Comput.-Aided. Mol. Des. 1996, 10, 255–262. 6530 dx.doi.org/10.1021/jm200312v |J. Med. Chem. 2011, 54, 6514–6530